MTC Y90

Drug Profile

MTC Y90

Alternative Names: MTC-Y90; MTC-Yttrium-90

Latest Information Update: 10 Dec 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator FeRx
  • Class
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Liver cancer; Solid tumours

Most Recent Events

  • 09 Oct 2003 Preclinical trials in Liver cancer in USA (Intra-arterial)
  • 09 Oct 2003 Preclinical trials in Solid tumours in USA (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top